Salvage chemotherapy for metastatic and recurrent ependymoma of childhood

Child's Nervous System

Volumn 25, Issue 10, 2009, Pages 1293-1301

  Bouffet, Eric ^a   Capra, Michael ^b   Bartels, Ute ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Chemotherapy; Metastatic ependymoma; Recurrent ependymoma

Indexed keywords

1 (2 CHLOROETHYL) 3 (2,6 DIOXO 3 PIPERIDYL) 1 NITROSOUREA; ALPHA INTERFERON; BETA INTERFERON; BUSULFAN; CARBOPLATIN; CILENGITIDE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ERLOTINIB; ETOPOSIDE; EVEROLIMUS; FOTEMUSTINE; GEFITINIB; IDARUBICIN; IFOSFAMIDE; IPROPLATIN; IRINOTECAN; METHOTREXATE; MITOLACTOL; PACLITAXEL; PREDNISONE; PROCARBAZINE; TAMOXIFEN; TEMOZOLOMIDE; THIOTEPA; TOPOTECAN; UNINDEXED DRUG; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOTOXICITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; EPENDYMOMA; HEARING IMPAIRMENT; HUMAN; INTRACRANIAL EPENDYMOMA; METASTASIS; MONOTHERAPY; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; SALVAGE THERAPY; TREATMENT RESPONSE;

BRAIN NEOPLASMS; CHILD; EPENDYMOMA; HUMANS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; SALVAGE THERAPY; SPINAL CORD NEOPLASMS;

EID: 69949168850     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-009-0883-x     Document Type: Article

References (85)

1. J Allen R Packer A Bleyer P Zeltzer M Prados A Nirenberg 1991 Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors J Clin Oncol 9 783 788
2. JC Allen L Helson 1981 High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children J Neurosurg 55 749 756
3. JC Allen C Hancock R Walker C Tan 1987 PCNU and recurrent childhood brain tumors J Neuro Oncol 5 241 244 (Pubitemid 18068605)
4. G Barone P Maurizi G Tamburrini R Riccardi 2006 Role of temozolomide in pediatric brain tumors Childs Nerv Syst 22 652 661
5. S Baruchel M Diezi D Hargrave D Stempak J Gammon A Moghrabi MJ Coppes CV Fernandez E Bouffet 2006 Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours Eur J Cancer 42 2335 2342
6. MW Ben Arush S Postovsky D Goldsher R el Hasid S Constantini 1999 Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen Pediatr Hematol Oncol 16 245 250
7. SJ Bertolone ES Baum W Krivit GD Hammond 1989 A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Children's Cancer Study Group J Neuro Oncol 7 5 11
8. SM Blaney R Heideman S Berg P Adamson A Gillespie JR Geyer R Packer K Matthay K Jaeckle D Cole N Kuttesch DG Poplack FM Balis 2003 Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis J Clin Oncol 21 143 147
9. L Bomgaars J Kerr S Berg J Kuttesch R Klenke SM Blaney 2006 A phase I study of irinotecan administered on a weekly schedule in pediatric patients Pediatr Blood Canc 46 50 55
10. E Bouffet G Perilongo A Canete M Massimino 1998 Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation Med Pediatr Oncol 30 319 329 discussion 329-331
11. AA Brandes G Cavallo M Reni A Tosoni L Nicolardi L Scopece E Franceschi G Sotti A Talacchi S Turazzi M Ermani 2005 A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia Cancer 104 143 148
12. A Broniscer S Gururangan TJ [tmp] MacDonald S Goldman RJ Packer CF Stewart D Wallace MK Danks HS Friedman TY Poussaint LE Kun JM Boyett A Gajjar 2007 Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report Clin Cancer Res 13 6712 6718 (Pubitemid 350206808)
13. WE Butler A Khan SA Khan 2002 Posterior fossa ependymoma with intense but transient disseminated enhancement but not metastasis Pediatr Neurosurg 37 27 31
14. RP Castleberry AH Ragab CP Steuber B Kamen S Toledano K Starling D Norris P Burger JP Krischer 1990 Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II study Investig New Drugs 8 401 406
15. MC Chamberlain MD Prados P Silver VA Levin 1988 A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors J Neuro Oncol 6 319 323
16. MC Chamberlain 2001 Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide Pediatr Neurol 24 117 121
17. P Chastagner D Sommelet-Olive C Kalifa M Brunat-Mentigny JM Zucker F Demeocq MC Baranzelli P Tron C Bergeron F Pein, et al. 1993 Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP) Med Pediatr Oncol 21 49 53
18. AM Comi JW Backstrom PC Burger PK Duffner 1998 Clinical and neuroradiologic findings in infants with intracranial ependymomas. Pediatric Oncology Group Pediatr Neurol 18 23 29
19. BJ Corden LC Strauss T Killmond BS Carson MD Wharam AJ Kumar S Piantadosi PA Robb PC Phillips 1991 Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors J Neuro Oncol 11 57 63
20. NC Daw WL Furman CF Stewart LC Iacono M Krailo ML Bernstein JE Dancey RA Speights SM Blaney JM Croop GH Reaman PC Adamson 2005 Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study J Clin Oncol 23 6172 6180 (Pubitemid 46300236)
21. L De Sio GM Milano A Castellano A Jenkner P Fidani C Dominici A Donfrancesco 2006 Temozolomide in resistant or relapsed pediatric solid tumors Pediatr Blood Canc 47 30 36
22. RT Dorr SE Salmon A Robertone E Bonnem 1988 Phase I-II trial of interferon-alpha 2b by continuous subcutaneous infusion over 28 days J Interferon Res 8 717 725
23. ZE Dreyer RP Kadota CF Stewart HS Friedman DH Mahoney LE Kun CW [tmp] McCluggage PC Burger J Kepner RL Heideman 2003 Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237 Neuro Oncol 5 261 267
24. LJ Ettinger D Sinniah SE Siegel LS Fishman HD Segall D Soni GA Bennetts DH Schultz D Raphael 1985 Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors J Neuro Oncol 3 263 269
25. LJ Ettinger N Ru M Krailo KS Ruccione W Krivit GD Hammond 1990 A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Children's Cancer Study Group J Neuro Oncol 9 69 76
26. LG Feun DJ Stewart ME Leavens MA Burgess N Savaraj RS Benjamin GP Bodey 1983 A phase II trial of 1-(2-chloroethyl)-3-(2, 6-dioxo-3-piperidyl)-1- nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors J Neuro Oncol 1 45 48
27. NK Foreman S Love SS Gill HB Coakham 1997 Second-look surgery for incompletely resected fourth ventricle ependymomas: technical case report Neurosurg 40 856 860 discussion 860
28. M Fouladi F Laningham J Wu MA O'Shaughnessy K Molina A Broniscer SL Spunt I Luckett CF Stewart PJ Houghton RJ Gilbertson WL Furman 2007 Phase I study of everolimus in pediatric patients with refractory solid tumors J Clin Oncol 25 4806 4812
29. H Frangoul MM Ames RB Mosher JM Reid MD Krailo NL Seibel DW Shaw PG Steinherz JA Whitlock JS Holcenberg 1999 Phase I study of topotecan administered as a 21-day continuous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group Clin Cancer Res 5 3956 3962
30. HS Friedman JP Krischer P Burger WJ Oakes B Hockenberger MD Weiner JM Falletta D Norris AH Ragab DH Mahoney Jr, et al. 1992 Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study J Clin Oncol 10 249 256
31. HS Friedman ME Dolan AE Pegg S Marcelli S Keir JJ Catino DD Bigner SC Schold Jr 1995 Activity of temozolomide in the treatment of central nervous system tumor xenografts Cancer Res 55 2853 2857
32. PS Gaynon LJ Ettinger ES Baum SE Siegel MD Krailo GD Hammond 1990 Carboplatin in childhood brain tumors. A Children's Cancer Study Group phase II trial Cancer 66 2465 2469
33. RJ Gilbertson L Bentley R Hernan TT Junttila AJ Frank H Haapasalo M Connelly C Wetmore T Curran K Elenius DW Ellison 2002 ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease Clin Cancer Res 8 3054 3064
34. JW Goldwein TA Glauser RJ Packer JL Finlay LN Sutton WJ Curran JM Laehy LB Rorke L Schut GJ D'Angio 1990 Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors Cancer 66 557 563
35. MK Gornet JC Buckner RS Marks BW Scheithauer BJ Erickson 1999 Chemotherapy for advanced CNS ependymoma J Neuro Oncol 45 61 67
36. J Grill C Kalifa F Doz C Schoepfer C Sainte-Rose D Couanet MJ Terrier-Lacombe D Valteau-Couanet O Hartmann 1996 A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study Pediatr Neurosurg 25 7 12
37. DR Hargrave E Bouffet J Gammon N Tariq RM Grant S Baruchel 2002 Phase I study of fotemustine in pediatric patients with refractory brain tumors Cancer 95 1294 1301
38. RL Heideman RJ Packer GH Reaman JC Allen B Lange ME Horowitz SM Steinberg A Gillespie EH Kovnar FM Balis, et al. 1993 A phase II evaluation of thiotepa in pediatric central nervous system malignancies Cancer 72 271 275
39. RL Heideman EC Douglass JA Langston JP Krischer PC Burger EH Kovnar LE Kun HS Friedman R Kadota 1995 A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study J Neuro Oncol 25 77 84
40. DC Hodgson LC Goumnerova JS Loeffler S Dutton PM Black E Alexander 3rd R Xu H Kooy B Silver NJ Tarbell 2001 Radiosurgery in the management of pediatric brain tumors Int J Radiat Oncol Biol Phys 50 929 935
41. S Hongeng TP Brent RA Sanford H Li LE Kun RL Heideman 1997 O6-Methylguanine-DNA methyltransferase protein levels in pediatric brain tumors Clin Cancer Res 3 2459 2463
42. CA Hurwitz LC Strauss J Kepner C Kretschmar MB Harris H Friedman L Kun R Kadota 2001 Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study J Pediatr Hematol Oncol 23 277 281 (Pubitemid 32662034)
43. RI Jakacki M Hamilton RJ Gilbertson SM Blaney J Tersak MD Krailo AM Ingle SD Voss JE Dancey PC Adamson 2008 Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study J Clin Oncol 26 4921 4927
44. M Johansen J Kuttesch WA Bleyer M Krailo M Ames T Madden 2006 Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group Clin Cancer Res 12 516 522 (Pubitemid 43166143)
45. RP Kadota CF Stewart M Horn JF Kuttesch Jr PC Burger JL Kepner LE Kun HS Friedman RL Heideman 1999 Topotecan for the treatment of recurrent or progressive central nervous system tumors-a pediatric oncology group phase II study J Neuro Oncol 43 43 47
46. MW Kieran RJ Packer A Onar SM Blaney P Phillips IF Pollack JR Geyer S Gururangan A Banerjee S Goldman CD Turner JB Belasco A Broniscer Y Zhu E Frank P Kirschmeier P Statkevich A Yver JM Boyett LE Kun 2007 Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study J Clin Oncol 25 3137 3143
47. MW Kieran JG Supko D Wallace R Fruscio TY Poussaint P Phillips I Pollack R Packer JM Boyett S Blaney A Banerjee R Geyer H Friedman S Goldman LE Kun T Macdonald 2008 Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors Pediatr Blood Canc 52 169 176
48. A Lassaletta P Perez-Olleros C Scaglione S Sirvent I De Prada A Perez-Martinez A Ruiz-Hernandez L Madero 2007 Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child J Neuro Oncol 83 303 306
49. VA Levin MS Edwards PH Gutin P Vestnys D Fulton M Seager CB Wilson 1984 Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma J Neurosurg 61 1063 1068
50. S Lowis I Lewis A Elsworth C Weston F Doz G Vassal R Bellott J Robert F Pein S Ablett R Pinkerton D Frappaz 2006 A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours Br J Cancer 95 571 580
51. TJ [tmp] MacDonald CF Stewart M Kocak S Goldman RG Ellenbogen P Phillips D Lafond TY Poussaint MW Kieran JM Boyett LE Kun 2008 Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012 J Clin Oncol 26 919 924
52. JR Madden LZ Fenton M Weil KR Winston M Partington NK Foreman 2001 Experience with tamoxifen/etoposide in the treatment of a child with myxopapillary ependymoma Med Pediatr Oncol 37 67 69
53. WP Mason S Goldman AJ Yates J Boyett H Li JL Finlay 1998 Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma-a report of the Children's Cancer Group J Neuro Oncol 37 135 143
54. F Mendrzyk A Korshunov A Benner G Toedt S Pfister B Radlwimmer P Lichter 2006 Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma Clin Cancer Res 12 2070 2079
55. TE Merchant M Fouladi 2005 Ependymoma: new therapeutic approaches including radiation and chemotherapy J Neuro Oncol 75 287 299
56. TE Merchant FA Boop LE Kun RA Sanford 2008 A retrospective study of surgery and reirradiation for recurrent ependymoma Int J Radiat Oncol Biol Phys 71 87 97
57. AF Mulne JM Ducore RD Elterman HS Friedman JP Krischer LE Kun JJ Shuster RP Kadota 2000 Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study J Pediatr Hematol Oncol 22 41 44
58. B Naylor 1964 The cytologic diagnosis of cerebrospinal fluid Acta Cytol 8 141 149
59. MN Needle PT Molloy JR Geyer A Herman-Liu JB Belasco JW Goldwein L Sutton PC Phillips 1997 Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors Med Pediatr Oncol 29 28 32
60. HS Nicholson CS Kretschmar M Krailo M Bernstein R Kadota D Fort H Friedman MB Harris N Tedeschi-Blok C Mazewski J Sato GH Reaman 2007 Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group Cancer 110 1542 1550
61. AH Ragab P Burger S Badnitsky J Krischer J Van Eys 1986 PCNU in the treatment of recurrent medulloblastoma and ependymoma-a POG Study J Neuro Oncol 3 341 342
62. C Ramachandran Z Khatib A Petkarou J Fort HB Fonseca SJ Melnick E Escalon 2004 Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells J Neuro Oncol 67 19 28
63. BI Razzouk RL Heideman HS Friedman JJ Jenkins LE Kun DL Fairclough ME Horowitz 1995 A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors Cancer 75 2762 2767
64. S Rehman C Brock ES Newlands 2006 A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy Am J Clin Oncol 29 106 107
65. AR Rezai HH Woo M Lee H Cohen D Zagzag FJ Epstein 1996 Disseminated ependymomas of the central nervous system J Neurosurg 85 618 624
66. LA Rodriguez M Prados P Silver VA Levin 1989 Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors Cancer 64 2420 2423
67. A Sandri M Massimino L Mastrodicasa N Sardi D Bertin ME Basso L Todisco A Paglino G Perilongo L Genitori L Valentini U Ricardi L Gandola F Giangaspero E Madon 2005 Treatment with oral etoposide for childhood recurrent ependymomas J Pediatr Hematol Oncol 27 486 490
68. I Sardi M Sanzo F Giordano A Sandri F Mussa PA Donati L Genitori 2008 Intracavitary chemotherapy (Gliadel) and oral low-dose etoposide for recurrent anaplastic ependymoma Oncol Rep 19 1219 1223
69. A Schiavetti G Varrasso P Maurizi C Cappelli A Clerico E Properzi MA Castello 2000 Ten-day schedule oral etoposide therapy in advanced childhood malignancies J Pediatr Hematol Oncol 22 119 124
70. CL Sexauer A Khan PC Burger JP Krischer J van Eys T Vats AH Ragab 1985 Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study Cancer 56 1497 1501
71. I Slavc E Schuller J Falger M Gunes K Pillwein T Czech W Dietrich K Rossler K Dieckmann D Prayer J Hainfellner 2003 Feasibility of long-term intraventricular therapy with mafosfamide (n∈=∈26) and etoposide (n∈=∈11): experience in 26 children with disseminated malignant brain tumors J Neuro Oncol 64 239 247
72. MM Souweidane E Bouffet J Finlay 1998 The role of chemotherapy in newly diagnosed ependymoma of childhood Pediatr Neurosurg 28 273 278
73. U Tabori J Ma M Carter M Zielenska J Rutka E Bouffet U Bartels D Malkin C Hawkins 2006 Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma J Clin Oncol 24 1522 1528
74. U Tabori V Wong J Ma M Shago N Alon J Rutka E Bouffet U Bartels D Malkin C Hawkins 2008 Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma Br J Cancer 99 1129 1135
75. JK Tam WG Bradley Jr SK Goergen DY Chen PJ Pema MD Dubin LM Teresi JE Jordan 1996 Patterns of contrast enhancement in the pediatric spine at MR imaging with single- and triple-dose gadolinium Radiol 198 273 278
76. SA Taylor JD [tmp] McCracken HJ Eyre RM O'Bryan BA Neilan 1985 Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study J Neuro Oncol 3 131 135
77. B Timmermann RD Kortmann J Kuhl C Meisner I Slavc T Pietsch M Bamberg 2000 Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91 Int J Radiat Oncol Biol Phys 46 287 295
78. CD Turner S Gururangan J Eastwood K Bottom M Watral R Beason RE [tmp] McLendon AH Friedman S Tourt-Uhlig LL Miller HS Friedman 2002 Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience Neuro Oncol 4 102 108
79. ET Valera HR Machado AC Santos RS de Oliveira D Araujo L Neder LG Tone 2005 The use of neoadjuvant chemotherapy to achieve complete surgical resection in recurring supratentorial anaplastic ependymoma Childs Nerv Syst 21 230 233
80. RW Walker JC Allen 1988 Cisplatin in the treatment of recurrent childhood primary brain tumors J Clin Oncol 6 62 66
81. KE Warren AA Aikin M Libucha BC Widemann E Fox RJ Packer FM Balis 2005 Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumors J Clin Oncol 23 7646 7653
82. S Weitman S Ochoa J Sullivan J Shuster N Winick C Pratt T Vietti M Harris 1997 Pediatric phase II cancer chemotherapy trials: a Pediatric Oncology Group study J Pediatr Hematol Oncol 19 187 191
83. MD Wiener OB Boyko HS Friedman B Hockenberger WJ Oakes 1990 False-positive spinal MR findings for subarachnoid spread of primary CNS tumor in postoperative pediatric patients AJNR Am J Neuroradiol 11 1100 1103
84. R Yoffe Y Khakoo IJ Dunkel M Souweidane E Lis C Sklar 2007 Recurrent ependymoma treated with high-dose tamoxifen in a peripubertal female: impact on tumor and the pituitary-ovarian axis Pediatr Blood Canc 49 758 760
85. S Zacharoulis A Levy SN Chi S Gardner M Rosenblum DC Miller I Dunkel B Diez R Sposto L Ji S Asgharzadeh J Hukin J Belasco R Dubowy S Kellie A Termuhlen J Finlay 2007 Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue Pediatr Blood Cancer 49 34 40